What's new? Log in Free sign up

Calliditas Therapeutics AB (CALT)

Company Profile

Company profile

Ticker

CALT

Exchange

Website

www.calliditas.se/

CEO

Renee J. Aguiar-Lucander

Incorporated

Location

Fiscal year end

Sector

Professional, Scientific, and Technical Services > Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co. • Alabama Power • Mississippi Power • Teva Pharmaceutical Industries Limited • Abbott Laboratories • Eli Lilly and • Bristol-Myers Squibb • Viatris ...

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

CALT stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Securities registration termination (foreign)

Exchange delisting

Third party tender offer statement (amended)

Tender offer solicitation (amended)

Notice of effectiveness

Third party tender offer statement (amended)

Voluntary exchange delisting

Registration of securities for employees (post-effective amendment)

Registration of securities for employees (post-effective amendment)

Prospectus update (post-effective amendment)

Latest ownership filings

View all

Asahi Kasei Corp

Asahi Kasei Corp

BIOTECHNOLOGY VALUE FUND L P

Asahi Kasei Corp

Asahi Kasei Corp

Asahi Kasei Corp

BIOTECHNOLOGY VALUE FUND L P

FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND

Swedbank Robur Fonder AB

Financial summary

Financial statements Chart CALT financial data

Quarter (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q2 2024

CALT institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	21	2	+950.0%
Opened positions	19	0	NEW
Closed positions	0	1	EXIT
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	32.51 bn	135.84 mm	+23836.8%
Total shares	41.88 mm	11.75 mm	+256.5%
Total puts	26.60 k	0.00	NEW
Total calls	8.50 k	0.00	NEW
Total put/call ratio	3.1	–	–

Largest owners	Shares	Value	Change
AHKSF Asahi Kasei	29.33 mm	$1.11 bn	NEW
Biotechnology Value Fund L P	6.26 mm	$0.00	0.0%
Linc AB	5.49 mm	$135.84 mm	0.0%
BVF	750.00 k	$29.24 bn	NEW
Optiver Holding B.V.	22.34 k	$870.88 mm	NEW
UBS UBS	10.76 k	$419.38 mm	NEW
PenderFund Capital Management	6.00 k	$320.04 mm	NEW
Susquehanna International	5.40 k	$210.43 mm	NEW
WFC Wells Fargo & Company	1.50 k	$58.49 mm	NEW
MS Morgan Stanley	919.00	$35.84 mm	NEW

Largest transactions	Shares	Bought/sold	Change
AHKSF Asahi Kasei	29.33 mm	+29.33 mm	NEW
BVF	750.00 k	+750.00 k	NEW
Optiver Holding B.V.	22.34 k	+22.34 k	NEW
UBS UBS	10.76 k	+10.76 k	NEW
PenderFund Capital Management	6.00 k	+6.00 k	NEW
Susquehanna International	5.40 k	+5.40 k	NEW
WFC Wells Fargo & Company	1.50 k	+1.50 k	NEW
MS Morgan Stanley	919.00	+919.00	NEW
Planning Capital Management	877.00	+877.00	NEW
BAC Bank of America	656.00	+656.00	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.